Jubilant Life Sciences Ltd - 530019 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Regarding Jubilant Chemsys Limited, A Wholly-Owned Subsidiary Company
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the prescribed particulars in Annexure-A. We request you to take the same on record. Jubilant Life Sciences Ltd - 530019 - Quarterly Results For The Quarter Ended December 31, 2018
In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended December 31, 2018 were approved by the Board of Directors of the Company at its meeting held today at 1.15 p.m. and concluded at 3.10 p.m. Pursuant to the applicable provisions of the Listing Regulations, we enclose the following: 1. The Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31, 2018; 2. Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said quarter; and 3. Copies of the Press Release and Presentation. We request you to take the same on records. Jubilant Life Sciences Ltd - 530019 - Intimation Pursuant To Regulation 57(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
This is to certify that the Company has duly made payment of half yearly interest for Non-Convertible Debentures - STRPP II, STRPP III and STRPP IV issued on private placement basis on the due date as per details attached. Jubilant Life Sciences Ltd - 530019 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of copies of newspaper advertisements In continuation of our letter dated January 25, 2019, we hereby enclose copies of the advertisements published on January 26, 2019, in MINT (English) and HINDUSTAN (Hindi) with respect to notice of the Board Meeting scheduled to be held on February 1, 2019. This is for your information and record. JUBILANT LIFE SCIENCES LIMITED - 530019 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of copies of newspaper advertisements In continuation of our letter dated January 25, 2019, we hereby enclose copies of the advertisements published on January 26, 2019, in MINT (English) and HINDUSTAN (Hindi) with respect to notice of the Board Meeting scheduled to be held on February 1, 2019. This is for your information and record. Jubilant Life Sciences Ltd - 530019 - Issuance Of Commercial Papers Of Rs. 100 Crore
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has issued Commercial Papers ('CPs') of Rs. 100 crore on January 25, 2019. Details of the same are attached. JUBILANT LIFE SCIENCES LIMITED - 530019 - Issuance Of Commercial Papers Of Rs. 100 Crore
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has issued Commercial Papers ('CPs') of Rs. 100 crore on January 25, 2019. Details of the same are attached. Jubilant Life Sciences Ltd - 530019 - Intimation Pursuant To Regulation 57(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
This is to certify that the Company has fully redeemed and made payment of interest for Non-Convertible Debentures - STRPP I issued on private placement basis on the due date as per details attached. JUBILANT LIFE SCIENCES LIMITED - 530019 - Schedule Of Investor Conference Call For Jubilant Life Sciences Limited - Unaudited Financial Results For The Quarter Ended December 31, 2018
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company is organising a Conference Call on February 1, 2019 after submission of the financial results for the quarter ended December 31, 2018 to the Stock Exchanges. Details of the Conference Call are attached. This is for information and record. JUBILANT LIFE SCIENCES LIMITED - 530019 - Board Meeting Intimation for Intimation Of Board Meeting - February 1, 2019
JUBILANT LIFE SCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2019 ,inter alia, to consider and approve In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, February 1, 2019, to inter-alia consider Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31, 2018. This is for information and record.